|
|
||||||||
The Annals of Thoracic Surgery, Vol 58, 478-482, Copyright © 1994 by The Society of Thoracic Surgeons
H Komai and SG Haworth
Soluble GMP-140 can prevent the adhesion of activated neutrophils to
endothelium in vitro. Because cardiopulmonary bypass causes neutrophil-
endothelial interaction, the plasma level of soluble GMP-140 was measured
using an enzyme immunoassay system in 32 children undergoing intracardiac
repair of congenital heart disease. They had either a high, low, or normal
pulmonary blood flow (n = 13, 12, and 7 respectively). Because activated
platelets are a source of GMP-140, the plasma beta-thromboglobulin level
was also measured. Blood was sampled before, during, and for 24 hours after
cardiopulmonary bypass. Plasma levels of both soluble GMP-140 and
beta-thromboglobulin increased after the onset of cardiopulmonary bypass in
all patients but for both substances the increase was greater in those with
a low pulmonary blood flow (p < 0.05 for all comparisons). The sum total
of soluble GMP-140 values during and after operation was correlated
negatively with the preoperative mean pulmonary arterial pressure (p <
0.05 for all time intervals). GMP-140 level correlated with the plasma
beta- thromboglobulin level (r = 0.5, p < 0.05). This work supports the
contention that soluble GMP-140 is released from activated platelets during
cardiopulmonary bypass, the level being particularly high in those who had
intrinsically abnormal platelets preoperatively in association with a low
pulmonary blood flow. Patients with a high pulmonary blood flow, who are
more susceptible to endothelial cell injury, may be less well protected by
soluble GMP-140.
ARTICLES
Effect of cardiopulmonary bypass on the circulating level of soluble GMP-140
Vascular Biology and Pharmacology Unit, Institute of Child Health, London, England.
This article has been cited by other articles:
![]() |
H. Komai, Y. Naito, and Y. Okamura Dextran sulfate as a leukocyte-endothelium adhesion molecule inhibitor of lung injury in pediatric open-heart surgery Perfusion, March 1, 2005; 20(2): 77 - 82. [Abstract] [PDF] |
||||
![]() |
M. P Vallely, P. G Bannon, C. F Hughes, and L. Kritharides Endothelial Cell Adhesion Molecules and Cardiopulmonary Bypass Asian Cardiovasc Thorac Ann, December 1, 2001; 9(4): 349 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Niimi, F. Ichinose, Y. Ishiguro, K. Terui, S. Uezono, S. Morita, and S. Yamane The Effects of Heparin Coating of Oxygenator Fibers on Platelet Adhesion and Protein Adsorption Anesth. Analg., September 1, 1999; 89(3): 573 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Smith and T. B. Spanier Aprotinin in deep hypothermic circulatory arrest Ann. Thorac. Surg., July 1, 1999; 68(1): 278 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Asimakopoulos and K. M. Taylor Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules Ann. Thorac. Surg., December 1, 1998; 66(6): 2135 - 2144. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Weerasinghe and K. M. Taylor The platelet in cardiopulmonary bypass Ann. Thorac. Surg., December 1, 1998; 66(6): 2145 - 2152. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Komai, Y. Naito, K. Fujiwara, Y. Takagaki, Y. Noguchi, and Y. Nishimura The protective effect of a leucocyte removal filter on the lung in open-heart surgery for ventricular septal defect Perfusion, January 1, 1998; 13(1): 27 - 34. [Abstract] [PDF] |
||||
![]() |
Y. J. Gu, A. J. deVries, P. W. Boonstra, and W. van Oeveren LEUKOCYTE DEPLETION RESULTS IN IMPROVED LUNG FUNCTION AND REDUCED INFLAMMATORY RESPONSE AFTER CARDIAC SURGERY J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 494 - 500. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |